Xiaole Shirley Liu

Xiaole Shirley Liu (Chinese: 刘小乐) is a computational biologist, cancer researcher, and entrepreneur. She has been a Professor in the Department of Data Sciences at the Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health. She co-founded [https://gv20tx.com/ GV20 Therapeutics] and, in early 2022, left DFCI to become its full-time CEO. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Xiaole Shirley Liu', query time: 0.01s Refine Results
  1. 1
    Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma

    Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma by Julia Paczkowska, Ming Tang, Kyle T. Wright, Li Song, Kelsey Luu, Vignesh Shanmugam, Emma L. Welsh, Jason L. Weirather, Naomi Besson, Harrison Olszewski, Billie A. Porter, Kathleen L. Pfaff, Robert A. Redd, Fathima Zumla Cader, Elisa Mandato, Jing Ouyang, Eleonora Calabretta, Gali Bai, Lee N. Lawton, Philippe Armand, Scott J. Rodig, Xiaole Shirley Liu, Margaret A. Shipp

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: